Home » Stocks » Cleveland BioLabs » Financials » Balance Sheet

Cleveland BioLabs, Inc. (CBLI)

Stock Price: $2.17 USD -0.08 (-3.56%)
Updated Jul 10, 2020 4:00 PM EDT - Market closed
After-hours: $2.18 +0.01 (0.46%) Jul 10, 6:41 PM

Cleveland BioLabs Balance Sheet (Annual)

The table below shows the annual balance sheet for Cleveland BioLabs stock for the past 16 years.

Numbers in millions USD. Fiscal year is January-December.
Year2019201820172016201520142013201220112010200920082007200620052004
Cash1.133.624.236.905.964.8012.9727.2322.8710.920.990.3214.243.081.22-
Short-Term Investments0.450.504.568.3413.70-0.312.635.520.46-1.001.002.052.38-
Cash & Equivalents1.584.128.7915.2519.664.8013.2829.8628.3911.380.991.3215.245.123.600.00
Cash Growth-61.7%-53.13%-42.33%-22.44%309.21%-63.82%-55.55%5.18%149.54%1053.26%-25.45%-91.32%197.43%42.31%--
Receivables0.380.250.550.350.630.270.460.041.745.383.391.050.210.200.04-
Other Current Assets0.050.100.230.290.40-1.53-2.58-0.500.880.990.360.490.300.420.220.00
Total Current Assets2.004.489.5815.8920.693.5511.1629.4131.0117.754.742.8615.755.743.85-
Property, Plant & Equipment0.020.030.020.040.120.240.460.991.080.940.861.091.190.400.31-
Long-Term Investments-----4.27----------
Goodwill and Intangibles---------1.160.930.730.460.250.08-
Other Long-Term Assets0.020.030.030.030.061.763.081.620.030.030.020.020.030.020.010.00
Total Long-Term Assets0.030.060.050.070.196.273.542.601.122.141.821.841.670.670.40-
Total Assets2.044.539.6315.9620.889.8114.7032.0132.1319.896.554.7117.426.424.25-
Accounts Payable0.260.140.200.340.201.060.791.520.911.261.211.100.710.690.26-
Current Debt-----2.650.440.07--------
Deferred Revenue----0.010.161.073.31-2.322.332.371.67-0.10-
Other Current Liabilities0.790.772.012.775.632.673.696.528.9726.849.820.700.850.080.030.00
Total Current Liabilities1.050.912.213.115.846.535.9911.439.8830.4213.354.173.230.770.39-
Long-term Debt-----1.507.130.10------0.30-
Other Long-Term Liabilities0.000.010.010.000.000.000.000.000.001.970.000.000.000.050.000.00
Total Long-Term Liabilities-0.010.01--1.507.130.10-1.97---0.050.30-
Total Liabilities1.050.922.223.115.848.0313.1111.529.8832.3913.354.173.230.820.70-
Total Debt-----4.157.560.17------0.30-
Debt Growth------45.17%4368.35%---------
Common Stock16316316315915813312612410980.3962.8956.7855.2318.378.760.00
Retained Earnings-167-164-160-151-148-134-136-118-100-96.05-69.69-56.25-41.04-12.78-5.18-
Comprehensive Income-0.57-0.61-0.52-0.56-0.41-0.380.310.550.08-0.03-----0.02-
Shareholders Equity-4.06-1.452.207.529.89-1.61-9.526.339.06-15.70-6.800.5414.195.593.56-
Total Liabilities and Equity-3.00-0.534.4210.6315.736.423.5917.8618.9416.696.554.7117.426.424.250.00
Net Cash / Debt1.584.128.7915.2519.660.665.7129.6928.3911.380.991.3215.245.123.300.00
Net Cash / Debt Growth-61.7%-53.13%-42.33%-22.44%2895.69%-88.51%-80.77%4.59%149.54%1053.26%-25.45%-91.32%197.43%55.39%--
Net Cash Per Share0.140.360.791.392.780.242.5415.8817.448.691.201.9625.2111.5010.550.00